Vertex Pharmaceuticals Inc. closed $62.04 short of its 52-week high ($510.64), which the company achieved on August 1st.

Corporate tax compliance software Vertex stock scores a breakout amid an array of acquisitions, as earnings growth begins to ...

On Friday, Vertex Inc (VERX) stock saw a decline, ending the day at $40.48 which represents a decrease of $-1.12 or -2.69% from the prior close of $41.6. The stock opened at $40.98 and touched a low ...

With the launch of Casgevy gaining momentum, Vertex Pharmaceuticals is adding another link to its gene-editing therapy supply ...

HOUSTON, September 06, 2024--(BUSINESS WIRE)--Vertex Energy, Inc. (NASDAQ ... the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, and the Company’s Quarterly Report ...

I congratulate the entire Vertex team on achieving HDI Support Center Certification,” said Tara Gibb, Senior Director, HDI. “As an HDI-Certified Support Center, Vertex is part of an elite circle of ...

In a report released today, Liisa Bayko from Evercore ISI maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), ...

Baird has recently initiated Vertex Inc (VERX) stock to Outperform rating, as announced on July 23, 2024, according to Finviz. Earlier, on March 1, 2024, BofA Securities had raised the stock from a ...

so that it is even easier for you to find content that matches your interests. Content presented to you on this service can be based on your content personalisation profiles, which can reflect ...

Google Cloud has made a series of upgrades to its Gemini generative artificial intelligence offering, including moving Gemini 1.5 Flash and Pro to general ... post about its Vertex AI machine ...

Construction delays, market share and renewable fuel programs: Here's what led Vertex Energy to file for bankruptcy protection.

Vertex Pharmaceuticals Inc. closed $45.56 below its 52-week high ($510.64), which the company achieved on August 1st.